Report period | 2019 | 2020 | 2021 | 2022 | 2023 | Q1 24 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, С$ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
SNDL:US | Sundial Growers, Inc. | Common share | - | CA86730L1094 | $1.99 |
Company name | Sundial Growers |
---|---|
Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals |
Business address | 919 11 AVENUE SW SUITE 200 CALGARY A0 T2R1P3 14039485227 |
Mailing address | 919 11 AVENUE SW SUITE 200 CALGARY A0 T2R1P3 |
Website | www.sndlgroup.com |